Envestnet Asset Management Inc Bio N Tech Se Transaction History

Envestnet Asset Management Inc

$299 Billion
Q1 2025

A detailed history of Envestnet Asset Management Inc transactions in Bio N Tech Se stock. As of the latest transaction made, Envestnet Asset Management Inc holds 8,762 shares of BNTX stock, worth $912,562. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,762

Previous 20,477 57.21%

Holding current value

$912,562

Previous $2.33 Million 65.84%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 29, 2025	SELL	$91.06 - $126.88 $1.07 Million - $1.49 Million	-11,715 Reduced 57.21%	8,762 $797,000
Q4 2024 Feb 12, 2025	SELL	$99.72 - $122.68 $47,466 - $58,395	-476 Reduced 2.27%	20,477 $2.33 Million
Q3 2024 Nov 06, 2024	SELL	$78.36 - $124.66 $7.85 Million - $12.5 Million	-100,228 Reduced 82.71%	20,953 $2.49 Million
Q2 2024 Aug 08, 2024	SELL	$80.36 - $102.87 $736,097 - $942,289	-9,160 Reduced 7.03%	121,181 $9.74 Million
Q1 2024 May 13, 2024	BUY	$88.96 - $112.35 $591,228 - $746,678	6,646 Added 5.37%	130,341 $12 Million
Q4 2023 Feb 13, 2024	BUY	$90.91 - $112.75 $10 Million - $12.4 Million	110,314 Added 824.41%	123,695 $13.1 Million
Q3 2023 Nov 13, 2023	SELL	$98.5 - $125.08 $250,879 - $318,578	-2,547 Reduced 15.99%	13,381 $1.45 Million
Q2 2023 Aug 04, 2023	SELL	$102.58 - $129.66 $98.1 Million - $124 Million	-956,607 Reduced 98.36%	15,928 $1.72 Million
Q1 2023 May 11, 2023	BUY	$122.57 - $153.67 $117 Million - $146 Million	952,932 Added 4861.15%	972,535 $121 Million
Q4 2022 Feb 07, 2023	BUY	$118.43 - $186.05 $18,119 - $28,465	153 Added 0.79%	19,603 $2.94 Million
Q3 2022 Nov 10, 2022	BUY	$127.65 - $183.11 $605,316 - $868,307	4,742 Added 32.24%	19,450 $2.62 Million
Q2 2022 Aug 03, 2022	BUY	$123.25 - $186.24 $205,581 - $310,648	1,668 Added 12.79%	14,708 $2.19 Million
Q1 2022 May 04, 2022	SELL	$126.25 - $231.85 $1.55 Million - $2.85 Million	-12,298 Reduced 48.54%	13,040 $2.22 Million
Q4 2021 Feb 04, 2022	BUY	$216.64 - $362.52 $1.63 Million - $2.73 Million	7,542 Added 42.38%	25,338 $6.53 Million
Q3 2021 Oct 07, 2021	BUY	$205.93 - $447.23 $698,308 - $1.52 Million	3,391 Added 23.54%	17,796 $4.86 Million
Q2 2021 Aug 04, 2021	BUY	$113.32 - $241.49 $876,076 - $1.87 Million	7,731 Added 115.84%	14,405 $3.23 Million
Q1 2021 May 04, 2021	BUY	$85.73 - $119.5 $572,162 - $797,543	6,674 New	6,674 $729,000

Others Institutions Holding BNTX

# of Institutions

365

Shares Held

39.5M

Call Options Held

3.01M

Put Options Held

2.01M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $25.3B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Bio N Tech Se Transaction History